rs772157816

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 3P and 1B. PM2PP5BP4

The NM_052988.5(CDK10):​c.1070G>A​(p.Arg357His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000131 in 1,598,750 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R357C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000012 ( 1 hom. )

Consequence

CDK10
NM_052988.5 missense

Scores

1
8
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:2U:1

Conservation

PhyloP100: 7.45

Publications

3 publications found
Variant links:
Genes affected
CDK10 (HGNC:1770): (cyclin dependent kinase 10) The protein encoded by this gene belongs to the CDK subfamily of the Ser/Thr protein kinase family. The CDK subfamily members are highly similar to the gene products of S. cerevisiae cdc28, and S. pombe cdc2, and are known to be essential for cell cycle progression. This kinase has been shown to play a role in cellular proliferation and its function is limited to cell cycle G2-M phase. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2009]
CDK10 Gene-Disease associations (from GenCC):
  • Al Kaissi syndrome
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 16-89695679-G-A is Pathogenic according to our data. Variant chr16-89695679-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 402152.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=1, Likely_pathogenic=1, Pathogenic=1}.
BP4
Computational evidence support a benign effect (MetaRNN=0.14610869). . Strength limited to SUPPORTING due to the PP5.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDK10NM_052988.5 linkc.1070G>A p.Arg357His missense_variant Exon 13 of 13 ENST00000353379.12 NP_443714.3 Q15131-1B7Z537

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDK10ENST00000353379.12 linkc.1070G>A p.Arg357His missense_variant Exon 13 of 13 1 NM_052988.5 ENSP00000338673.7 Q15131-1

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152266
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000901
AC:
2
AN:
221856
AF XY:
0.00000828
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000200
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000124
AC:
18
AN:
1446484
Hom.:
1
Cov.:
32
AF XY:
0.0000125
AC XY:
9
AN XY:
718792
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33188
American (AMR)
AF:
0.00
AC:
0
AN:
43402
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25864
East Asian (EAS)
AF:
0.0000257
AC:
1
AN:
38986
South Asian (SAS)
AF:
0.0000238
AC:
2
AN:
84054
European-Finnish (FIN)
AF:
0.0000206
AC:
1
AN:
48594
Middle Eastern (MID)
AF:
0.000174
AC:
1
AN:
5750
European-Non Finnish (NFE)
AF:
0.0000108
AC:
12
AN:
1106836
Other (OTH)
AF:
0.0000167
AC:
1
AN:
59810
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152266
Hom.:
0
Cov.:
33
AF XY:
0.0000269
AC XY:
2
AN XY:
74392
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41468
American (AMR)
AF:
0.00
AC:
0
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5198
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10632
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68048
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.542
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Abnormal brain morphology Pathogenic:1
-
Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:research

- -

Al Kaissi syndrome Pathogenic:1
-
Laboratory of Medical Genetics (UMR_S 1112), INSERM/Strasbourg University
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Uncertain:1
Jul 28, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1070G>A (p.R357H) alteration is located in exon 13 (coding exon 13) of the CDK10 gene. This alteration results from a G to A substitution at nucleotide position 1070, causing the arginine (R) at amino acid position 357 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Uncertain
0.069
T
BayesDel_noAF
Benign
-0.14
CADD
Pathogenic
28
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.014
T;T
Eigen
Benign
0.18
Eigen_PC
Uncertain
0.31
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.83
T;T
M_CAP
Uncertain
0.12
D
MetaRNN
Benign
0.15
T;T
MetaSVM
Benign
-0.42
T
MutationAssessor
Uncertain
2.2
.;M
PhyloP100
7.4
PrimateAI
Uncertain
0.50
T
PROVEAN
Benign
-0.77
N;N
REVEL
Benign
0.28
Sift
Uncertain
0.0040
D;D
Sift4G
Uncertain
0.010
D;D
Polyphen
1.0
.;D
Vest4
0.41
MutPred
0.31
.;Loss of MoRF binding (P = 0.003);
MVP
0.60
MPC
0.58
ClinPred
0.96
D
GERP RS
4.9
Varity_R
0.27
gMVP
0.52
Mutation Taster
=49/51
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs772157816; hg19: chr16-89762087; API